Main outcome measure
Three studies were included, two comparing oral penicillin to oral
penicillin plus metronidazole, one comparing IM/oral penicillin to
IM/oral sulbactam-ampicillin. Clinical outcomes were assessed in all,
including recurrence rate, symptom improvement and duration of pyrexia.